SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001636050-20-000117
Filing Date
2020-12-18
Accepted
2020-12-18 06:00:56
Documents
17
Period of Report
2020-12-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K siox-20201216.htm   iXBRL 8-K 47752
2 EX-1.1 sioxex1112182020.htm EX-1.1 324332
3 EX-5.1 sioxex51121820.htm EX-5.1 13288
9 GRAPHIC cooley2a.jpg GRAPHIC 24723
  Complete submission text file 0001636050-20-000117.txt   636703

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20201216.xsd EX-101.SCH 2418
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT siox-20201216_cal.xml EX-101.CAL 710
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT siox-20201216_def.xml EX-101.DEF 1647
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20201216_lab.xml EX-101.LAB 27194
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20201216_pre.xml EX-101.PRE 14239
10 EXTRACTED XBRL INSTANCE DOCUMENT siox-20201216_htm.xml XML 12639
Mailing Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036
Business Address 11 TIMES SQUARE 33RD FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 981333697 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37418 | Film No.: 201397910
SIC: 2834 Pharmaceutical Preparations